Align Aspartate kinase; Aspartokinase; EC 2.7.2.4 (characterized)
to candidate WP_011802264.1 PNAP_RS14430 aspartate kinase
Query= SwissProt::Q88EI9 (411 letters) >NCBI__GCF_000015505.1:WP_011802264.1 Length = 422 Score = 519 bits (1336), Expect = e-152 Identities = 268/420 (63%), Positives = 334/420 (79%), Gaps = 14/420 (3%) Query: 1 MALIVQKFGGTSVGSIERIEQVAEKVKKHREAGDDLVVVLSAMSGETNRLIDLAKQI--- 57 MALIV K+GGTS+GS ERI VA++V K AG +VVV SAMSGETNRL+ LAK++ Sbjct: 1 MALIVHKYGGTSMGSTERIRNVAKRVAKWARAGHQMVVVPSAMSGETNRLLGLAKELAPA 60 Query: 58 -TDQPVPRELDVIVSTGEQVTIALLTMALIKRGVPAVSYTGNQVRILTDSSHNKARILQI 116 +D RELD + +TGEQ + ALL +AL G+PAVSY G QV I T+S++ KARI I Sbjct: 61 QSDDTYSRELDALAATGEQASSALLAIALQAEGMPAVSYAGWQVTIKTNSAYTKARIESI 120 Query: 117 DDQKIRADLKEGRVVVVAGFQGVDEHGSITTLGRGGSDTTGVALAAALKADECQIYTDVD 176 DD+K+RADL G+VV++ GFQG+DE G++TTLGRGGSDT+ VA+AAALKA EC IYTDVD Sbjct: 121 DDEKVRADLDAGKVVIITGFQGMDEGGNVTTLGRGGSDTSAVAIAAALKAHECLIYTDVD 180 Query: 177 GVYTTDPRVVPQARRLEKITFEEMLEMASLGSKVLQIRSVEFAGKYNVPLRVLHSFKE-- 234 GVYTTDPRVVP+ARRL+ ++FEEMLEMAS+GSKVLQIRSVEFAGKY VPLRVL SF + Sbjct: 181 GVYTTDPRVVPEARRLQTVSFEEMLEMASMGSKVLQIRSVEFAGKYKVPLRVLSSFTDWN 240 Query: 235 -------GPGTLITIDEEESMEQPIISGIAFNRDEAKLTIRGVPDTPGVAFKILGPISAS 287 GTLI+ +E+E ME+ I+SGIAFNRDEAK+++ GVPDTPG+A++ILG ++ + Sbjct: 241 IDINEEARSGTLISFEEDEKMEKAIVSGIAFNRDEAKISVLGVPDTPGIAYQILGAVADA 300 Query: 288 NIEVDMIVQNVAHDNTTDFTFTVHRNEYEKAQSVLEN-TAREIGAREVIGDTKIAKVSIV 346 NIEVD+I+QN++ D TDF+FTVHRN++ K +L++ +GA+EV GD +I KVSIV Sbjct: 301 NIEVDVIIQNISKDGKTDFSFTVHRNDFAKTLDLLKSKVVPALGAQEVTGDARICKVSIV 360 Query: 347 GVGMRSHAGVASCMFEALAKESINIQMISTSEIKVSVVLEEKYLELAVRALHTAFDLDAP 406 G+GMRSH G+AS MF LA+E INIQMISTSEIK SVV++EKY+ELAVRALH AFDLD P Sbjct: 361 GIGMRSHVGIASKMFRVLAEEGINIQMISTSEIKTSVVIDEKYMELAVRALHKAFDLDQP 420 Lambda K H 0.316 0.133 0.358 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 553 Number of extensions: 19 Number of successful extensions: 4 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 411 Length of database: 422 Length adjustment: 31 Effective length of query: 380 Effective length of database: 391 Effective search space: 148580 Effective search space used: 148580 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.6 bits) S2: 50 (23.9 bits)
Align candidate WP_011802264.1 PNAP_RS14430 (aspartate kinase)
to HMM TIGR00657 (aspartate kinase (EC 2.7.2.4))
# hmmsearch :: search profile(s) against a sequence database # HMMER 3.3.1 (Jul 2020); http://hmmer.org/ # Copyright (C) 2020 Howard Hughes Medical Institute. # Freely distributed under the BSD open source license. # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - # query HMM file: ../tmp/path.aa/TIGR00657.hmm # target sequence database: /tmp/gapView.8228.genome.faa # - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Query: TIGR00657 [M=442] Accession: TIGR00657 Description: asp_kinases: aspartate kinase Scores for complete sequences (score includes all domains): --- full sequence --- --- best 1 domain --- -#dom- E-value score bias E-value score bias exp N Sequence Description ------- ------ ----- ------- ------ ----- ---- -- -------- ----------- 7.2e-135 436.4 7.4 2.9e-132 427.8 7.4 2.0 1 lcl|NCBI__GCF_000015505.1:WP_011802264.1 PNAP_RS14430 aspartate kinase Domain annotation for each sequence (and alignments): >> lcl|NCBI__GCF_000015505.1:WP_011802264.1 PNAP_RS14430 aspartate kinase # score bias c-Evalue i-Evalue hmmfrom hmm to alifrom ali to envfrom env to acc --- ------ ----- --------- --------- ------- ------- ------- ------- ------- ------- ---- 1 ! 427.8 7.4 2.9e-132 2.9e-132 1 440 [. 1 415 [. 1 417 [. 0.95 Alignments for each domain: == domain 1 score: 427.8 bits; conditional E-value: 2.9e-132 TIGR00657 1 maliVqKFGGtSvgnverikkvakivkkekekgnqvvVVvSAmagvTdaLvelaekvsseeekelieki 69 maliV K+GGtS+g+ eri++vak+v k ++ g+q+vVV SAm+g T++L+ la+++ + ++ lcl|NCBI__GCF_000015505.1:WP_011802264.1 1 MALIVHKYGGTSMGSTERIRNVAKRVAKWARAGHQMVVVPSAMSGETNRLLGLAKELAPAQSD------ 63 899**********************************************************31...... PP TIGR00657 70 rekhlealeelasqalkeklkallekeleevkkereldlilsvGEklSaallaaaleelgvkavsllga 138 +reld++ ++GE+ S+alla al+++g+ avs+ g+ lcl|NCBI__GCF_000015505.1:WP_011802264.1 64 ------------------------------DTYSRELDALAATGEQASSALLAIALQAEGMPAVSYAGW 102 ..............................12389********************************** PP TIGR00657 139 eagiltdsefgrAkvleeikterleklleegiivvvaGFiGatekgeittLGRGGSDltAallAaalkA 207 + i t+s++++A+ +e+i+ e++ + l++g++v+++GF+G++e g++ttLGRGGSD++A+++AaalkA lcl|NCBI__GCF_000015505.1:WP_011802264.1 103 QVTIKTNSAYTKAR-IESIDDEKVRADLDAGKVVIITGFQGMDEGGNVTTLGRGGSDTSAVAIAAALKA 170 **************.****************************************************** PP TIGR00657 208 deveiytDVdGiytaDPrivpeArrldeisyeEalELaslGakvLhprtlepamrakipivvkstf... 273 +e+ iytDVdG+yt+DPr+vpeArrl+++s+eE+lE+as+G+kvL+ r++e+a ++k+p++v s+f lcl|NCBI__GCF_000015505.1:WP_011802264.1 171 HECLIYTDVDGVYTTDPRVVPEARRLQTVSFEEMLEMASMGSKVLQIRSVEFAGKYKVPLRVLSSFtdw 239 ****************************************************************98444 PP TIGR00657 274 .....npeaeGTlivaksk.seeepavkalsldknqalvsvsgttmkpgilaevfgalaeakvnvdlil 336 ++ GTli +++ ++e+ +v+++++++++a++sv g+++ pgi+ +++ga+a+a+++vd+i+ lcl|NCBI__GCF_000015505.1:WP_011802264.1 240 nidinEEARSGTLISFEEDeKMEKAIVSGIAFNRDEAKISVLGVPDTPGIAYQILGAVADANIEVDVII 308 4444234568****9877779999********************************************* PP TIGR00657 337 qsssets...isfvvdkedadkakellkkkvkeekaleevevekklalvslvGagmksapgvaakifea 402 q++s+++ sf+v+++d k+ llk+kv + +ev+ + ++++vs+vG gm+s+ g+a+k+f + lcl|NCBI__GCF_000015505.1:WP_011802264.1 309 QNISKDGktdFSFTVHRNDFAKTLDLLKSKVVPALGAQEVTGDARICKVSIVGIGMRSHVGIASKMFRV 377 ****666667******************999999999******************************** PP TIGR00657 403 Laeeniniemissseikisvvvdekdaekavealhekl 440 Laee+ini+mis+seik svv+dek++e av+alh+++ lcl|NCBI__GCF_000015505.1:WP_011802264.1 378 LAEEGINIQMISTSEIKTSVVIDEKYMELAVRALHKAF 415 ************************************98 PP Internal pipeline statistics summary: ------------------------------------- Query model(s): 1 (442 nodes) Target sequences: 1 (422 residues searched) Passed MSV filter: 1 (1); expected 0.0 (0.02) Passed bias filter: 1 (1); expected 0.0 (0.02) Passed Vit filter: 1 (1); expected 0.0 (0.001) Passed Fwd filter: 1 (1); expected 0.0 (1e-05) Initial search space (Z): 1 [actual number of targets] Domain search space (domZ): 1 [number of targets reported over threshold] # CPU time: 0.04u 0.01s 00:00:00.05 Elapsed: 00:00:00.05 # Mc/sec: 3.53 // [ok]
This GapMind analysis is from Apr 10 2024. The underlying query database was built on Apr 09 2024.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see:
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory